{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:16:21Z","timestamp":1794651381741,"version":"4.9.1"},"reference-count":44,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Children with nonmalignant hematological disorders (NMHD) often require numerous red blood cell transfusions before hematopoietic stem cell transplantation (HSCT), leading to iron overload. Ferritin and liver iron concentration (LIC) are used to estimate the degree of iron overload to determine eligibility for HSCT, but neither marker has been definitively associated with poorer HSCT outcomes in pediatric cohorts. We conducted a multicenter retrospective cohort study using PEDSnet to examine the association between elevated pre-HSCT ferritin and LIC and HSCT outcomes and to evaluate iron reduction therapy after transplantation. A total of 580 patients with a pre-HSCT ferritin and 260 patients with a pre-HSCT LIC were studied. Patients with high pre-HSCT ferritin of &amp;gt;2500 ng\/mL had decreased 3-year overall survival (adjusted hazard ratio [HR], 2.31; 95% confidence interval [CI], 1.06-5.04). A sensitivity analysis demonstrated this trend only in patients with severe aplastic anemia (SAA). Elevated ferritin was associated with a markedly increased risk of bacteremia after HSCT in patients with SAA (HR, 3.33; 95% CI, 1.72-6.44). Elevated pre-HSCT LIC of &amp;gt;5 mg Fe\/g dry weight was not associated with decreased survival, bacteremia, graft failure, or veno-occlusive disease (VOD). VOD was assessed only in patients undergoing busulfan-based transplantation. After transplantation, 63% of patients in the multicenter analysis had an elevated ferritin, whereas 68% had an elevated LIC. Chelation and phlebotomy were equally effective in reducing post-HSCT iron. These results challenge the use of LIC as the gold standard for iron-related risk stratification in HSCT. Further research into peri-HSCT iron management is necessary in an era of expanding availability of HSCT for NMHD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017942","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:22:26Z","timestamp":1770236546000},"page":"3324-3334","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Impact of iron overload on hematopoietic stem cell transplantation in pediatric patients with nonmalignant hematological disorders"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7577-0179","authenticated-orcid":false,"given":"Nora M.","family":"Gibson","sequence":"first","affiliation":[{"name":"1Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhat","family":"Nguyen","sequence":"additional","affiliation":[{"name":"3Applied Clinical Research Center, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-242X","authenticated-orcid":false,"given":"Sandra","family":"Amaral","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"4Division of Nephrology, Children's Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1522-6534","authenticated-orcid":false,"given":"Jesse","family":"Hsu","sequence":"additional","affiliation":[{"name":"5Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-8553","authenticated-orcid":false,"given":"Meghan","family":"Haney","sequence":"additional","affiliation":[{"name":"6Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn E.","family":"Heimbruch","sequence":"additional","affiliation":[{"name":"6Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Sabulski","sequence":"additional","affiliation":[{"name":"6Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9877-8041","authenticated-orcid":false,"given":"Ashley","family":"Zurawel","sequence":"additional","affiliation":[{"name":"7Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0597-5475","authenticated-orcid":false,"given":"Kimberly A.","family":"Davidow","sequence":"additional","affiliation":[{"name":"8Lisa Dean Mosely Foundation Institute for Cancer and Blood Disorders, Nemours Children's Health, Delaware, Wilmington, DE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1207-8457","authenticated-orcid":false,"given":"Katherine T.","family":"Lind","sequence":"additional","affiliation":[{"name":"9Division of Bone Marrow Transplantation and Cellular Therapy, Children's Hospital Colorado, Aurora, CO"},{"name":"10Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1967-6276","authenticated-orcid":false,"given":"Samantha","family":"Scanlon","sequence":"additional","affiliation":[{"name":"7Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0285-307X","authenticated-orcid":false,"given":"Heather","family":"Alva","sequence":"additional","affiliation":[{"name":"11Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Department of Pediatrics, Lucile Packard Children\u2019s Hospital at Stanford University, Palo Alto, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2257-9665","authenticated-orcid":false,"given":"Lisa","family":"Hall","sequence":"additional","affiliation":[{"name":"12Division of Hematology, Oncology, and Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Charles","family":"Bailey","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"3Applied Clinical Research Center, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1288-1960","authenticated-orcid":false,"given":"Timothy S.","family":"Olson","sequence":"additional","affiliation":[{"name":"1Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Kwiatkowski","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"},{"name":"13Division of Hematology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"2","key":"2026052610370108500_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2174\/1871530316666160506150516","article-title":"Gonadal hormones in adolescent females with \u03b2-thalassemia in relation to iron load","volume":"16","author":"Hagag","year":"2016","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"6","key":"2026052610370108500_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.blre.2018.04.004","article-title":"Iron toxicity - its effect on the bone marrow","volume":"32","author":"Isidori","year":"2018","journal-title":"Blood Rev"},{"key":"2026052610370108500_bib3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1749-6632.1998.tb10479.x","article-title":"Survival and disease complications in thalassemia major","volume":"850","author":"Borgna-Pignatti","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"2026052610370108500_bib4","first-page":"371","article-title":"Iron toxicity and chelation therapy in hematopoietic stem cell transplant","volume":"27","author":"Isidori","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"7","key":"2026052610370108500_bib5","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2003-03-0807","article-title":"Labile plasma iron in iron overload: redox activity and susceptibility to chelation","volume":"102","author":"Esposito","year":"2003","journal-title":"Blood"},{"issue":"10","key":"2026052610370108500_bib6","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3324\/haematol.2018.193128","article-title":"Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice","volume":"103","author":"Jin","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"2026052610370108500_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00277-007-0321-7","article-title":"The oxidative status of blood cells in a murine model of graft-versus-host disease","volume":"86","author":"Amer","year":"2007","journal-title":"Ann Hematol"},{"issue":"3","key":"2026052610370108500_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5045\/br.2015.50.3.140","article-title":"Hepatic veno-occlusive disease may develop in secondary iron overloaded mice after allogeneic hematopoietic stem cell transplantation with total body irradiation","volume":"50","author":"Yeom","year":"2015","journal-title":"Blood Res"},{"issue":"2","key":"2026052610370108500_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2008.11.012","article-title":"Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Kataoka","year":"2009","journal-title":"Biol Blood Marrow Transpl"},{"issue":"7","key":"2026052610370108500_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"N Engl J Med"},{"issue":"5","key":"2026052610370108500_bib11","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.V87.5.2082.2082","article-title":"Marrow transplantation for patients with thalassemia: results in class 3 patients","volume":"87","author":"Lucarelli","year":"1996","journal-title":"Blood"},{"issue":"10","key":"2026052610370108500_bib12","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1182\/blood-2006-10-054924","article-title":"Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation","volume":"109","author":"Armand","year":"2007","journal-title":"Blood"},{"issue":"8","key":"2026052610370108500_bib13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bbmt.2014.04.024","article-title":"Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis","volume":"20","author":"Armand","year":"2014","journal-title":"Biol Blood Marrow Transpl"},{"issue":"12","key":"2026052610370108500_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/bmt.2009.88","article-title":"Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children","volume":"44","author":"Lee","year":"2009","journal-title":"Bone Marrow Transpl"},{"issue":"3","key":"2026052610370108500_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MPG.0000000000000235","article-title":"Ferritin and LIC: predicting liver injury in children with sickle cell","volume":"58","author":"Smith","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"2026052610370108500_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/MPH.0000000000001726","article-title":"Liver stiffness measurement by vibration controlled transient elastography does not correlate to hepatic iron overload in children with sickle cell disease","volume":"42","author":"Costa","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"2026052610370108500_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/MPH.0000000000002433","article-title":"Assessment of liver fibrosis by transient elastography in children and young adults with sickle cell disease with and without iron overload","volume":"44","author":"Alvarez","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"2026052610370108500_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ajh.23188","article-title":"Does iron overload really matter in stem cell transplantation?","volume":"87","author":"Armand","year":"2012","journal-title":"Am J Hematol"},{"key":"2026052610370108500_bib19","unstructured":"Treosulfan-based conditioning regimen before a blood or bone marrow transplant for the treatment of bone marrow failure diseases (BMT CTN 1904). Updated 5 September 2025. ClinicalTrials.gov identifier: NCT04965597. Accessed 12 February 2026. https:\/\/clinicaltrials.gov\/study\/NCT04965597."},{"issue":"5","key":"2026052610370108500_bib20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa2113206","article-title":"Betibeglogene autotemcel gene therapy for non-\u03b20\/\u03b20 genotype \u03b2-thalassemia","volume":"386","author":"Locatelli","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"2026052610370108500_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ejh.12123","article-title":"Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation","volume":"91","author":"Virtanen","year":"2013","journal-title":"Eur J Haematol"},{"issue":"9","key":"2026052610370108500_bib22","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2013-04-499772","article-title":"Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content","volume":"122","author":"Trottier","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2026052610370108500_bib23","first-page":"642","article-title":"Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the American Society for Transplantation and Cellular Therapy","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transpl Cell Ther"},{"issue":"2","key":"2026052610370108500_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European Society for Blood and Marrow Transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"2026052610370108500_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/aje\/155.2.176","article-title":"Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology","volume":"155","author":"Hern\u00e1n","year":"2002","journal-title":"Am J Epidemiol"},{"key":"2026052610370108500_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1749-6632.1998.tb10483.x","article-title":"Bone marrow transplantation in thalassemia. The experience of Pesaro","volume":"850","author":"Lucarelli","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"2026052610370108500_bib27","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna-Pignatti","year":"2004","journal-title":"Haematologica"},{"issue":"4","key":"2026052610370108500_bib28","first-page":"304","article-title":"Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine","volume":"32","author":"Giardina","year":"1995","journal-title":"Semin Hematol"},{"issue":"3","key":"2026052610370108500_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3324\/haematol.2009.011429","article-title":"Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study","volume":"95","author":"Alessandrino","year":"2010","journal-title":"Haematologica"},{"issue":"9","key":"2026052610370108500_bib30","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3390\/jcm10092008","article-title":"Hyperferritinemia-A clinical overview","volume":"10","author":"Sandnes","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"2026052610370108500_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood"},{"issue":"8","key":"2026052610370108500_bib32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00277-013-1737-x","article-title":"Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease","volume":"92","author":"Gro\u00dfekatth\u00f6fer","year":"2013","journal-title":"Ann Hematol"},{"issue":"8","key":"2026052610370108500_bib33","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/bmt.2017.93","article-title":"Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection","volume":"52","author":"Ohmoto","year":"2017","journal-title":"Bone Marrow Transpl"},{"issue":"9","key":"2026052610370108500_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/sj.bmt.1705340","article-title":"Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients","volume":"37","author":"Miceli","year":"2006","journal-title":"Bone Marrow Transpl"},{"issue":"suppl 1","key":"2026052610370108500_bib35","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1089\/sur.2005.6.s1-41","article-title":"Iron and the risk of infection","volume":"6","author":"Pieracci","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"issue":"4","key":"2026052610370108500_bib36","first-page":"507","article-title":"The effect of parenteral iron administration on the development of Staphylococcus aureus-induced experimental pyelonephritis in rats","volume":"71","author":"An\u011f","year":"1990","journal-title":"Int J Exp Pathol"},{"issue":"4","key":"2026052610370108500_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.V94655","article-title":"Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency","volume":"9","author":"Patruta","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2026052610370108500_bib38","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/516481","article-title":"Iron overload alters innate and T helper cell responses to Candida albicans in mice","volume":"175","author":"Mencacci","year":"1997","journal-title":"J Infect Dis"},{"issue":"12","key":"2026052610370108500_bib39","doi-asserted-by":"crossref","first-page":"e70037","DOI":"10.1111\/ctr.70037","article-title":"Prognostic factors associated with increased mortality in pediatric veno-occlusive disease following hematopoietic cell transplantation","volume":"38","author":"Zaidman","year":"2024","journal-title":"Clin Transpl"},{"issue":"3","key":"2026052610370108500_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1399-3046.2008.00983.x","article-title":"Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Chotsampancharoen","year":"2009","journal-title":"Pediatr Transpl"},{"issue":"1","key":"2026052610370108500_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/bmt.2016.205","article-title":"Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study","volume":"52","author":"Sirvent","year":"2017","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"2026052610370108500_bib42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/pbc.26213","article-title":"One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation","volume":"64","author":"Inati","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2026052610370108500_bib43","doi-asserted-by":"crossref","first-page":"e0238793","DOI":"10.1371\/journal.pone.0238793","article-title":"Outcome of iron reduction therapy in ex-thalassemics","volume":"16","author":"Aboobacker","year":"2021","journal-title":"PLoS One"},{"issue":"4","key":"2026052610370108500_bib44","first-page":"349","article-title":"International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update","volume":"30","author":"Rotz","year":"2024","journal-title":"Transpl Cell Ther"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/10\/3324\/2518745\/blooda_adv-2025-017942-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/10\/3324\/2518745\/blooda_adv-2025-017942-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:37:12Z","timestamp":1779806232000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/10\/3324\/566425\/Impact-of-iron-overload-on-hematopoietic-stem-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017942","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,26]]},"published":{"date-parts":[[2026,5,13]]}}}